News
Cigna's Evernorth is signaling that it will expand its GLP-1 medication offerings through the creation of Evernorth EnReachRx, a new patient support model for pharmacies that want to provide enhanced ...
Cigna beat investor expectations on earnings and revenue in the second quarter as the insurer reported strong growth in its Evernorth health services arm. The company reported revenue of $57.8 ...
Cigna, which includes Evernorth Health Services and one of the nation’s largest pharmacy benefit management companies, said first quarter net income was $1.3 billion, or $4.85 per share ...
Cigna's solid Q2 results boosted by Evernorth revenue growth, limited exposure to elevated medical costs By Dave Muoio Jul 31, 2025 3:30pm Cigna Evernorth Earnings pharmacy benefit management ...
Among the 751 people randomly assigned to receive weekly injections of either the maximum dose of Wegovy or the maximum dose of Zepbound for a year and three months, those taking Zepbound lost ...
Hosted on MSN29d
The Patients Forced to Switch From Zepbound to Wegovy - MSN
Duffy is among thousands of Americans being forced to switch from Zepbound to Wegovy as a result of new coverage restrictions by pharmacy-benefit manager CVS Caremark, a unit of CVS Health that ...
Nearly 32% of Zepbound users ultimately lost at least a quarter of their body weight, compared with just 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women.
Global health company The Cigna Group completed its fourth round of layoffs this year at its New Jersey-based subsidiary Cigna Evernorth Health Services last week. Evernorth, which provides ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results